Whereas interference with two major pathways leading to NFκB activation exerts beneficial effects in experimental colitis and anti-cancer treatment, our data indicate that activation of NFκB-mediated responses protects cytokine-challenged cardiomyocytes and inflammatory cells and argues against a significant contribution of NFκB to cytokine induction in viral heart disease. This evidence concerns the gene NFKB1 and colitis.